Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...
During a Case-Based Roundtable® event, Julie R. Brahmer, MD, MSC, reviewed the CheckMate 9LA, KEYNOTE-407, and POSEIDON ...
New data showed that prior malignancy may influence survival outcomes in patients with metastatic colorectal cancer, ...
News Medical on MSN11d
Microglia reprogramming offers novel strategy to combat melanoma brain metastasesThis research represents a significant breakthrough in understanding the interactions between the brain's immune system and ...
San Francisco, US Tuesday, February 18, 2025, 09:00 Hrs [IST] ...
Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") reports continued favorable efficacy results from the 10-month follow-up visit for the fourth patient enrolled in its Deltacel-01 ...
(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Joseph Allen discussing PSA response and survival based on metastatic site in patients with ...
HER2, a HER2-targeted immunotherapy, with plans for FDA submission following promising Phase 2b data in osteosarcoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback